APO Research
Talk to an analyst

APO RESEARCH · REPORT

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Growth and Trends Forecast to 2032

22 December 2025102 pages

Choose your research edition.

Industry ResearchLeber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) include Alkeus Pharmaceuticals, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech, ProQR Therapeutics and Spark Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market by Company

Alkeus Pharmaceuticals

Biovista

Editas Medicine

GenSight Biologics

Ixchel Pharma

Khondrion

Mitotech

ProQR Therapeutics

Spark Therapeutics

Stealth BioTherapeutics

Usher Syndrome

Amgen

Sanofi

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type

Dominant Optic Atrophy

Recessive Optic Atrophy

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application

Hospitals

Medical Research Institute

Eye Clinics

Other

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dominant Optic Atrophy Table 2. Major Company of Recessive Optic Atrophy Table 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (k pcs) Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type (2021-2026) Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2021-2026) & (US$/pcs) Table 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2027-2032) & (k pcs) Table 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type (2027-2032) Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2027-2032) & (US$/pcs) Table 14. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (k pcs) Table 15. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (k pcs) Table 17. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (k pcs) Table 19. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (k pcs) Table 21. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (k pcs) Table 23. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2021-2026) & (US$ Million) Table 24. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends Table 25. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Drivers Table 26. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Opportunities and Challenges Table 27. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Restraints Table 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Company (2021-2026) Table 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Company (2021-2026) & (k pcs) Table 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Company (2021-2026) Table 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Price by Company (2021-2026) & (US$/pcs) Table 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Company Production Sites and Headquarters Table 35. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Company, Product Type & Application Table 36. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2021-2026) & (k pcs) Table 41. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Region (2021-2026) Table 44. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2027-2032) & (k pcs) Table 46. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Region (2027-2032) Table 49. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 50. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (k pcs) Table 52. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application (2021-2026) Table 55. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2021-2026) & (US$/pcs) Table 56. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2027-2032) & (k pcs) Table 57. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application (2027-2032) Table 60. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2027-2032) & (US$/pcs) Table 61. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (k pcs) Table 62. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (k pcs) Table 64. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (k pcs) Table 66. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (k pcs) Table 68. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (k pcs) Table 70. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2021-2026) & (US$ Million) Table 71. Alkeus Pharmaceuticals Company Information Table 72. Alkeus Pharmaceuticals Business Overview Table 73. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 75. Alkeus Pharmaceuticals Recent Development Table 76. Biovista Company Information Table 77. Biovista Business Overview Table 78. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 80. Biovista Recent Development Table 81. Editas Medicine Company Information Table 82. Editas Medicine Business Overview Table 83. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 84. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 85. Editas Medicine Recent Development Table 86. GenSight Biologics Company Information Table 87. GenSight Biologics Business Overview Table 88. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 89. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 90. GenSight Biologics Recent Development Table 91. Ixchel Pharma Company Information Table 92. Ixchel Pharma Business Overview Table 93. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 94. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 95. Ixchel Pharma Recent Development Table 96. Khondrion Company Information Table 97. Khondrion Business Overview Table 98. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 99. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 100. Khondrion Recent Development Table 101. Mitotech Company Information Table 102. Mitotech Business Overview Table 103. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 104. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 105. Mitotech Recent Development Table 106. ProQR Therapeutics Company Information Table 107. ProQR Therapeutics Business Overview Table 108. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 109. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 110. ProQR Therapeutics Recent Development Table 111. Spark Therapeutics Company Information Table 112. Spark Therapeutics Business Overview Table 113. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 114. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 115. Spark Therapeutics Recent Development Table 116. Stealth BioTherapeutics Company Information Table 117. Stealth BioTherapeutics Business Overview Table 118. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 119. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 120. Stealth BioTherapeutics Recent Development Table 121. Usher Syndrome Company Information Table 122. Usher Syndrome Business Overview Table 123. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 124. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 125. Usher Syndrome Recent Development Table 126. Amgen Company Information Table 127. Amgen Business Overview Table 128. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 129. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 130. Amgen Recent Development Table 131. Sanofi Company Information Table 132. Sanofi Business Overview Table 133. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 134. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio Table 135. Sanofi Recent Development Table 136. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 137. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 138. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2026) Table 139. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032) & (k pcs) Table 140. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Country (2027-2032) Table 141. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country (2021-2026) Table 144. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share Forecast by Country (2027-2032) Table 146. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 147. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 148. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2026) Table 149. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032) & (k pcs) Table 150. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country (2021-2026) Table 154. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 158. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032) & (k pcs) Table 160. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country (2021-2026) Table 164. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share Forecast by Country (2027-2032) Table 166. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 167. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 168. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2026) Table 169. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032) & (k pcs) Table 170. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country (2021-2026) Table 174. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026) & (k pcs) Table 178. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032) & (k pcs) Table 180. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country (2021-2026) Table 184. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List Table 189. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Image Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size (2021-2032) & (US$ Million) Figure 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2021-2032) & (k pcs) Figure 5. Dominant Optic Atrophy Image Figure 6. Global Dominant Optic Atrophy Sales YoY Growth (2021-2032) & (k pcs) Figure 7. Recessive Optic Atrophy Image Figure 8. Global Recessive Optic Atrophy Sales YoY Growth (2021-2032) & (k pcs) Figure 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type 2025 VS 2032 Figure 11. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2025 Figure 12. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2025 Figure 13. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (k pcs) Figure 25. Medical Research Institute Image Figure 26. Global Medical Research Institute Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Eye Clinics Image Figure 28. Global Eye Clinics Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application 2025 VS 2032 Figure 33. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2025 Figure 34. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2025 Figure 35. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application in 2025 Figure 43. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 44. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 48. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 52. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 56. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 60. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Dominant Optic Atrophy
  • Recessive Optic Atrophy
Applications
  • Hospitals
  • Medical Research Institute
  • Eye Clinics
  • Other
Companies covered
  • Alkeus Pharmaceuticals
  • Biovista
  • Editas Medicine
  • GenSight Biologics
  • Ixchel Pharma
  • Khondrion
  • Mitotech
  • ProQR Therapeutics
  • Spark Therapeutics
  • Stealth BioTherapeutics
  • Usher Syndrome
  • Amgen
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market by Type
  6. 1.3.1 Dominant Optic Atrophy
  7. 1.3.2 Recessive Optic Atrophy
  8. 1.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
  9. 1.4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
  2. 2.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Drivers
  3. 2.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Opportunities and Challenges
  4. 2.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2021-2026)
  2. 3.2 Global Top Players by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2021-2026)
  3. 3.3 Global Top Players by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (2021-2026)
  4. 3.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Company Production Sites & Headquarters
  6. 3.6 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Company, Product Type & Application
  7. 3.7 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Tier 1, Tier 2, and Tier 3
4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Regional Status and Outlook
  1. 4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size by Region
  3. 4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Region
  7. 4.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application
  1. 5.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Medical Research Institute
  4. 5.1.3 Eye Clinics
  5. 5.1.4 Other
  6. 5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
  7. 5.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alkeus Pharmaceuticals
  2. 6.1.1 Alkeus Pharmaceuticals Company Information
  3. 6.1.2 Alkeus Pharmaceuticals Business Overview
  4. 6.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  6. 6.1.5 Alkeus Pharmaceuticals Recent Developments
  7. 6.2 Biovista
  8. 6.2.1 Biovista Company Information
  9. 6.2.2 Biovista Business Overview
  10. 6.2.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  12. 6.2.5 Biovista Recent Developments
  13. 6.3 Editas Medicine
  14. 6.3.1 Editas Medicine Company Information
  15. 6.3.2 Editas Medicine Business Overview
  16. 6.3.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  18. 6.3.5 Editas Medicine Recent Developments
  19. 6.4 GenSight Biologics
  20. 6.4.1 GenSight Biologics Company Information
  21. 6.4.2 GenSight Biologics Business Overview
  22. 6.4.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  24. 6.4.5 GenSight Biologics Recent Developments
  25. 6.5 Ixchel Pharma
  26. 6.5.1 Ixchel Pharma Company Information
  27. 6.5.2 Ixchel Pharma Business Overview
  28. 6.5.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  30. 6.5.5 Ixchel Pharma Recent Developments
  31. 6.6 Khondrion
  32. 6.6.1 Khondrion Company Information
  33. 6.6.2 Khondrion Business Overview
  34. 6.6.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  36. 6.6.5 Khondrion Recent Developments
  37. 6.7 Mitotech
  38. 6.7.1 Mitotech Company Information
  39. 6.7.2 Mitotech Business Overview
  40. 6.7.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  42. 6.7.5 Mitotech Recent Developments
  43. 6.8 ProQR Therapeutics
  44. 6.8.1 ProQR Therapeutics Company Information
  45. 6.8.2 ProQR Therapeutics Business Overview
  46. 6.8.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  48. 6.8.5 ProQR Therapeutics Recent Developments
  49. 6.9 Spark Therapeutics
  50. 6.9.1 Spark Therapeutics Company Information
  51. 6.9.2 Spark Therapeutics Business Overview
  52. 6.9.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  54. 6.9.5 Spark Therapeutics Recent Developments
  55. 6.10 Stealth BioTherapeutics
  56. 6.10.1 Stealth BioTherapeutics Company Information
  57. 6.10.2 Stealth BioTherapeutics Business Overview
  58. 6.10.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  60. 6.10.5 Stealth BioTherapeutics Recent Developments
  61. 6.11 Usher Syndrome
  62. 6.11.1 Usher Syndrome Company Information
  63. 6.11.2 Usher Syndrome Business Overview
  64. 6.11.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  66. 6.11.5 Usher Syndrome Recent Developments
  67. 6.12 Amgen
  68. 6.12.1 Amgen Company Information
  69. 6.12.2 Amgen Business Overview
  70. 6.12.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  72. 6.12.5 Amgen Recent Developments
  73. 6.13 Sanofi
  74. 6.13.1 Sanofi Company Information
  75. 6.13.2 Sanofi Business Overview
  76. 6.13.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
  78. 6.13.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
  2. 7.1.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026)
  4. 7.1.3 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
  6. 7.2.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026)
  8. 7.2.3 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
  2. 8.1.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026)
  4. 8.1.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
  6. 8.2.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
  2. 9.1.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
  6. 9.2.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
  2. 10.1.1 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026)
  4. 10.1.3 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
  6. 10.2.1 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026)
  8. 10.2.3 South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
  2. 11.1.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
  6. 11.2.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Value Chain Analysis
  2. 12.1.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process
  7. 12.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
  10. 12.2.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst